IJR News — today's news from every sideArgex Plans Q2 2026 Earnings ReleaseBusiness — Jul 20, 2026Across pharma, property, utilities, and biotech, investors await Argonex's Q2 2026 results with consensus ESP and revenue, while Argosy Property, Avantor, Avangrid, and UroGen Pharma all show steady or improving revenue, dividends, and profitability signals, reflecting ongoing demand, portfolio discipline, and cost management. The overall tone across these sectors remains cautious optimism as earnings trends and pipeline progress support valuation in diversified portfolios.
